ISRCTN52952998已完成未知
ong-term follow up of patients who participated in previous Vasculitis trials
Skane University Hospital Malmö-Lund, Sweden0 个研究点目标入组 875 人开始时间: 2010年5月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 875
研究概览
简要总结
- 2011 results in: http://www.ncbi.nlm.nih.gov/pubmed/21109517 2. 2011 results in: http://www.ncbi.nlm.nih.gov/pubmed/21156667 3. 2011 results in: http://www.ncbi.nlm.nih.gov/pubmed/21890618 4. 2011 results in: http://www.ncbi.nlm.nih.gov/pubmed/21452269 5. 2011 results in: http://www.ncbi.nlm.nih.gov/pubmed/21616914 6. 2012 results in: http://www.ncbi.nlm.nih.gov/pubmed/22614882 7. 2012 results in: http://www.ncbi.nlm.nih.gov/pubmed/21953279 8. 2012 results in: http://www.ncbi.nlm.nih.gov/pubmed/22128076 9. 2013 results in: http://www.ncbi.nlm.nih.gov/pubmed/23615499 10. 2013 results in: http://www.ncbi.nlm.nih.gov/pubmed/22962314 11. 2013 results in: http://www.ncbi.nlm.nih.gov/pubmed/23380137 12. 2015 results in: http://www.ncbi.nlm.nih.gov/pubmed/26016754 13. 2015 results in: http://www.ncbi.nlm.nih.gov/pubmed/25601266 14. 2015 results in: http://www.ncbi.nlm.nih.gov/pubmed/25205825 15. 2015 results in: http://www.ncbi.nlm.nih.gov/pubmed/24243925 16. 2016 results in: http://www.ncbi.nlm.nih.gov/pubmed/27973575 17. 2017 results in: https://arthritis-research.biomedcentral.com/articles/10.1186/s13075-017-1321-1 18. 2017 results in: http://www.ncbi.nlm.nih.gov/pubmed/28053275
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •Current participant inclusion criteria as of 11/07/2019:
- •1. Patients with newly diagnosed Anti-Neutrophil Cytoplasm Antibody Vasculitis recruited into one of EUVAS’ randomized controlled trials, NORAM, CYCAZAREM, MEPEX, CYCLOPS, RITUXVAS, IMPROVE, MYCYC performed by European Vasculitis Society (EUVAS)
- •Previous participant inclusion criteria:
- •1. Patients with newly diagnosed Anti-Neutrophil Cytoplasm Antibody Vasculitis recruited into one of four randomised controlled trials, NORAM, CYCAZAREM, MEPEX, CYCLOPS performed by European Vasculitis Study Group
- •2. The patients were recruited during the period of 1995 to 2002
排除标准
- •1. Patients withdrawn from original study due to incorrect diagnosis
- •2. Consent withheld by patient
研究者
相似试验
已完成
不适用
Risk of cervical cancer among women who took an HPV test in 1990-1992, a 30-year follow-up studyInvestigating the risk of CIN3+ in patients with an HPV test at UNN in 1990-1992Urological and Genital DiseasesISRCTN10836802niversity Hospital of North Norway642
招募中
1 期
ong-term Follow-up Study for Participants Previously Treated with Ciltacabtagene AutoleucelMedDRA version: 21.0Level: LLTClassification code: 10028228Term: Multiple myeloma Class: 10029104Multiple MyelomaCTIS2023-505530-10-00Janssen - Cilag International365
进行中（未招募）
1 期
ong-term Follow-up Study for Participants Previously Treated with Ciltacabtagene AutoleucelMultiple MyelomaEUCTR2020-005521-84-ESJanssen-Cilag International NV400
尚未招募
4 期
ong-term Follow-up Study for Participants Previously Treated with Ciltacabtagene Autoleucelplasma cell myeloma10040778Multiple MyelomaNL-OMON53393Janssen-Cilag International NV6
进行中（未招募）
1 期
ong-term Follow-up Study for Participants Previously Treated with Ciltacabtagene AutoleucelMedDRA version: 21.0Level: LLTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 100000004864Multiple MyelomaEUCTR2020-005521-84-NLJanssen-Cilag International NV400